VRDN - Viridian Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VRDN is currently covered by 13 analysts with an average price target of $35.26. This is a potential upside of $19.32 (121.2%) from yesterday's end of day stock price of $15.94.

Viridian Therapeutics's activity chart (see below) currently has 35 price targets and 93 ratings on display. The stock rating distribution of VRDN is 94.03% BUY and 5.97% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 13.88% with an average time for these price targets to be met of 108.88 days.

Highest price target for VRDN is $61, Lowest price target is $22, average price target is $36.64.

Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 20-May-2025. First documented stock forecast 20-Jan-2021.

Currently out of the existing stock ratings of VRDN, 63 are a BUY (94.03%), 4 are a HOLD (5.97%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$36

$20.12 (126.70%)

$36

27 days ago
(20-May-2025)

0/16 (0%)

$22.18 (160.49%)

Buy

$38

$22.12 (139.29%)

$38

1 months 9 days ago
(07-May-2025)

2/8 (25%)

$25.71 (209.19%)

369

Buy

$27

$11.12 (70.03%)

$31

1 months 9 days ago
(07-May-2025)

1/3 (33.33%)

$14.71 (119.69%)

112

Buy

$34

$18.12 (114.11%)

$34

1 months 24 days ago
(23-Apr-2025)

1/15 (6.67%)

$20.49 (151.67%)

40

Hold

$27

$11.12 (70.03%)

$37

5 months 28 days ago
(19-Dec-2024)

0/2 (0%)

$8.27 (44.15%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VRDN (Viridian Therapeutics) average time for price targets to be met?

On average it took 108.88 days on average for the stock forecasts to be realized with a an average price target met ratio 13.88

Which analyst has the current highest performing score on VRDN (Viridian Therapeutics) with a proven track record?

JASON BUTLER

Which analyst has the most public recommendations on VRDN (Viridian Therapeutics)?

Jason Butler works at JMP and has 5 price targets and 3 ratings on VRDN

Which analyst is the currently most bullish on VRDN (Viridian Therapeutics)?

Julian Harrison with highest potential upside - $45.12

Which analyst is the currently most reserved on VRDN (Viridian Therapeutics)?

Michael Higgins with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?